Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma
Small · 2023
DOI: 10.1002/smll.202302280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2023. Verfasst von Maxine Sy Lam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Singapore, 138673, Singapore. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: A*STAR Career Development Fund, Singapore Ministry of Health's National Medical Research Council, Clinician Scientist - Individual Research.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most common primary malignant brain cancer in adults with a dismal prognosis. Temozolomide (TMZ) is the first‐in‐line chemotherapeutic; however, resistance is frequent and multifactorial. While many molecular and genetic factors have been linked to TMZ resistance, the role of the solid tumor morphology and the tumor microenvironment, particularly the blood‐brain barrier (BBB), is unknown. Here, the authors investigate these using a complex in vitro model for GBM and its surrounding BBB. The model recapitulates important clinical features such as a dense tumor core with tumor cells that invade along the perivascular space; and a perfusable BBB with a physiological permeability and morphology that is altered in the presence of a tumor spheroid. It is demonstrated that TMZ sensitivity decreases with increasing cancer cell spatial organization, and that the BBB can contribute to TMZ resistance. Proteomic analysis with next‐generation low volume sample workflows of these cultured microtissues revealed potential clinically relevant proteins involved in tumor aggressiveness and TMZ resistance, demonstrating the utility of complex in vitro models for interrogating the tumor microenvironment and therapy validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Singapore, 138673, Singapore.
- Functional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A∗STAR), 61 Biopolis Drive, Singapore, 138673, Singapore.
- Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience Institute, Singapore, 308433, Singapore.
- Duke-National University of Singapore Medical School, Singapore, 169857, Singapore.
- School of Biological Sciences, Nanyang Technological University, Singapore, 637551, Singapore.
- Department of Neurosurgery, National Neuroscience Institute, Singapore, 308433, Singapore.
ORCID-Profile: Maxine Sy Lam, Andrea Pavesi
Förderung
- A*STAR Career Development Fund
- Singapore Ministry of Health's National Medical Research Council
- Clinician Scientist - Individual Research
- Open Fund-Large Collaborative
- A.P., N.B. and R.M.S. are supported by A*STAR Core funding
Zitieren
APA
Lam, M. S., Aw, J. J., Tan, D., Vijayakumar, R., Lim, H. Y. G., Yada, S., Pang, Q. Y., Barker, N., Tang, C., Ang, B. T., Sobota, R. M., & Pavesi, A. (2023). Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma. Small. https://doi.org/10.1002/smll.202302280
Vancouver
Lam MS, Aw JJ, Tan D, Vijayakumar R, Lim HYG, Yada S, et al. Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma. Small. 2023. doi:10.1002/smll.202302280
BibTeX
@article{Lam2023,
author = {Lam, Maxine Sy and Aw, Joey Jy and Tan, Damien and Vijayakumar, Ragavi and Lim, Hui Yi Grace and Yada, Swathi and Pang, Qing You and Barker, Nick and Tang, Carol and Ang, Beng Ti and Sobota, Radoslaw M and Pavesi, Andrea},
title = {Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma},
journal = {Small},
year = {2023},
doi = {10.1002/smll.202302280}
}
EUVIMED